|
2BTP
14-3-3 Protein Theta (Human) Complexed to Peptide
Deposited 2005-06-05
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–234(234 aa)
Chain B
1–234(234 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;0.2M SODIUM ACETATE TRIHYDRATE, 0.1M TRISHCL PH8.5,30% PEG4000, pH 8.50
|
Resolution 2.80 Å
R-free 0.259
|
|
5IQP
14-3-3 PROTEIN TAU ISOFORM
Deposited 2016-03-11
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–245(245 aa)
Chain B
1–245(245 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;291 K;24% PEG4K, 140 mM LI2SO4, 4 % of
SATURATED NACL IN 80 mM MES AT pH 6.4; PROTEIN 7 mg/ml
|
Resolution 2.60 Å
R-free 0.239
|
|
6BD2
Complex of 14-3-3 theta with an IRSp53 peptide doubly-phosphorylated at T340 and S366
Deposited 2017-10-20
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–245(245 aa)
Chain B
1–245(245 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 1
1PE PENTAETHYLENE GLYCOL × 1
PG4 TETRAETHYLENE GLYCOL × 1
PGE TRIETHYLENE GLYCOL × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291.15 K;0.1 M CaCl2, 13% Peg 3350
|
Resolution 2.90 Å
R-free 0.254
|
|
6BQT
Complex of 14-3-3 theta with an IRSp53 peptide doubly-phosphorylated at T340 and T360
Deposited 2017-11-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–245(245 aa)
Chain B
1–245(245 aa)
|
Not recorded
|
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
1PE PENTAETHYLENE GLYCOL × 3
EDO 1,2-ETHANEDIOL × 1
PG4 TETRAETHYLENE GLYCOL × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291.15 K;0.1 M CaCl2, 13% Peg 3350
|
Resolution 2.80 Å
R-free 0.287
|
|
6BQT
Complex of 14-3-3 theta with an IRSp53 peptide doubly-phosphorylated at T340 and T360
Deposited 2017-11-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–245(245 aa)
Chain E
1–245(245 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
PG4 TETRAETHYLENE GLYCOL × 2
PGE TRIETHYLENE GLYCOL × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291.15 K;0.1 M CaCl2, 13% Peg 3350
|
Resolution 2.80 Å
R-free 0.287
|
|
6BQT
Complex of 14-3-3 theta with an IRSp53 peptide doubly-phosphorylated at T340 and T360
Deposited 2017-11-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
1–245(245 aa)
Chain H
1–245(245 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 2
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291.15 K;0.1 M CaCl2, 13% Peg 3350
|
Resolution 2.80 Å
R-free 0.287
|
|
6BQT
Complex of 14-3-3 theta with an IRSp53 peptide doubly-phosphorylated at T340 and T360
Deposited 2017-11-28
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain J
1–245(245 aa)
Chain K
1–245(245 aa)
|
Not recorded
|
1PE PENTAETHYLENE GLYCOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;291.15 K;0.1 M CaCl2, 13% Peg 3350
|
Resolution 2.80 Å
R-free 0.287
|
|
6KZG
14-3-3 protein in Complex with CIC S301 phosphorylated peptide
Deposited 2019-09-24
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–234(233 aa)
Chain B
2–234(233 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;8% v/v TacsimateTM pH 6.0, 20% w/v Polyethylene glycol 3350
|
Resolution 2.00 Å
R-free 0.231
|
|
6KZH
14-3-3 protein in Complex with CIC S173 phosphorylated peptide
Deposited 2019-09-24
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–234(233 aa)
Chain B
2–234(233 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M Sodium chloride, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350
|
Resolution 2.65 Å
R-free 0.274
|
|
7QI1
Crystal structure of human 14-3-3 protein beta in complex with CFTR peptide pS753pS768 and PPI stabilizer CY007424
Deposited 2021-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: octameric
|
Chain A
1–230(230 aa)
Chain B
1–230(230 aa)
Chain C
1–230(230 aa)
Chain D
1–230(230 aa)
|
Not recorded
|
ARG ARGININE × 2
Q95 [2-(2-methylphenyl)sulfanylphenyl]methanamine × 2
TYR TYROSINE × 2
GLN GLUTAMINE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;Qiagen Cryos Suite #44 (0.09 M HEPES sodium salt pH7.5, 1.26M tri-sodium citrate, 10% (v/v) glycerol) with an extra 2% (v/v) of glycerol.
|
Resolution 1.76 Å
R-free 0.241
|